Category In The News
In partnership with UCSF and MD Anderson, ABC2 brought together researchers from leading medical centers and biotech companies to strategize new therapeutic paths to treat Low Grade Gliomas.
Max Wallace, CEO of Accelerate Brain Cancer Cure, guest blogs for The Case Foundation about our new project that could revolutionize treatment for patients.
Josh Sommer is the founder of the Chordoma Foundation. He is a good friend and we work closely with his organization on a variety of rare disease initiatives.
Max will join a panel of R&D experts to discuss "The Evolving Research Enterprise: The Role of Foundations and Strategic Funding."
Max Wallace, CEO of Accelerate Brain Cancer Cure, provides perspective on the latest Avastin trial results by Genentech.
A Unique Opportunity To Learn About The Most Innovative New Trends In Brain Tumor Research.
A blog post from Max Wallace, CEO of Accelerate Brain Cancer Cure.